HC Wainwright Issues Pessimistic Estimate for YMAB Earnings
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Research analysts at HC Wainwright dropped their Q2 2025 EPS estimates for Y-mAbs Therapeutics in a research report issued on Monday, May 19th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($0.23) for the quarter, down from their prior […]
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Research analysts at HC Wainwright dropped their Q2 2025 EPS estimates for Y-mAbs Therapeutics in a research report issued on Monday, May 19th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($0.23) for the quarter, down from their prior […]
